Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Industry Watch.
Press releases published on April 2, 2025

AC Immune Reports Further Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease
AC Immune Reports Further Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease Active immunotherapy with ACI-7104.056 induces high anti-a-synuclein (a-syn) antibody levels on average over 20-fold …

Global NK Cell Therapy Clinical Trials FDA Approval Patent Market Size Report 2025
Delhi, April 02, 2025 (GLOBE NEWSWIRE) -- Global Natural Killer (NK) Cell Therapy Clinical Trials, Proprietary Technologies, Collaborations and Market Opportunity Insight 2025 Report Highlights and Findings: Global …

VISTA Inhibitor Clinical Trials Market Size FDA Approval Patent Report 2025
Delhi, April 02, 2025 (GLOBE NEWSWIRE) -- Global VISTA Inhibitor Clinical Trials, Drug Development Opportunities …

Helsinn Group submits a new formulation of AKYNZEO® to the European Medicines Agency (EMA)
Lugano, Switzerland – April 2, 2025 – Helsinn Group (“Helsinn”), a global pharmaceutical company with a track record of nearly fifty years of commercial execution and a strong focus in supportive care, oncology and dermato-oncology, today announced the …

AVEROA Receives Positive Opinion from the European Medicines Agency for XOANACYL®, an Oral Therapy for Chronic Kidney Disease (CKD)
CHMP recommends approval for XOANACYL, an oral therapy for use in the following therapeutic areas: Iron deficiency, chronic renal failure and hyperphosphatemia Final European Commission decision expected by June 2025; UK regulatory submission foreseen via …

Boehringer Ingelheim reaches more patients in 2024 and prepares new medicine launches
Number of patients reached in 2024 jumps 8% to 66 million R…

ENA Respiratory Announces Publication Supporting the Potential of its Novel Intranasal Therapy INNA-051 to Reduce the Impact of Viral Respiratory Infections in Older Adults
Clinical studies demonstrated that INNA-051’s natural defence boosting mechanism is effective in older adults Administration of INNA-051 to older adults (65 years old) in a Phase 1 study was well-tolerated and increased important antiviral host-defence …

CMR Surgical secures more than $200M to accelerate growth
CMR Surgical has closed a financing round of more than $200 million, backed by existing investors and new investor Trinity Capital The latest funding will fuel the global commercialisation of its Versius Surgical Robotic System, particularly in the U.S. …

Press Release Biocartis NV: Biocartis Announces Launch of the Brand-New Idylla™ POLE-POLD1 Mutation Assay
PRESS RELEASE 02/04/2025, 07:00 CEST Biocartis Announces Launch of the Brand-New Idylla™ POLE-POLD1 Mutation Assay Mechelen, Belgium, 02 April 2025 – Biocartis NV (“Biocartis”), an innovative molecular diagnostics company, is pleased to announce the launch …

Curium Announces Approval of Generic DTPA - Kit for the Preparation of Technetium Tc 99m Pentetate Injection in the U.S.
ST. LOUIS, April 02, 2025 (GLOBE NEWSWIRE) -- Curium announced today that the U.S. Food and Drug Administration approved its generic version of the Kit for the Preparation of Technetium Tc 99m Pentetate Injection, often referred to as DTPA ( …

Gluco6 Review Exposed (SHOCKING FINDINGS): Why Doctors Are Calling This the Glucose Game-Changer
JUPITER, FL, April 02, 2025 (GLOBE NEWSWIRE) -- Gluco6 If you’ve been battling unstable blood sugar, low energy, relentless sugar cravings, or that creeping weight gain that won’t budge — you’re not alone. Millions are searching for a way to support …

Endoscopic Ultrasonography Market to Hit US$1.93 Billion by 2029 with 7.1% CAGR | MarketsandMarkets™.
Delray Beach, FL, April 01, 2025 (GLOBE NEWSWIRE) -- The global endoscopic ultrasonography market, valued at US$1.28 billion in 2023, is forecasted to grow at a robust CAGR of 7.1%, reaching US$1.37 billion in 2024 and an impressive US$1.93 billion by 2029 …

Respilean Drops Exposed (MUST-READ): The Truth About Lung Support Big Pharma Doesn’t Want You to Know
JUPITER, FLORIDA, April 02, 2025 (GLOBE NEWSWIRE) -- RESPILEAN In a world where we measure everything—from step counts to calories—there’s one thing we rarely track until it’s already compromised: our lung health. With pollution rising, allergens becoming …

Global Healing’s Oxy-Powder® Demonstrates Powerful Gut Health Benefits in Citruslabs Study
Global Healing's Oxy-Powder® demonstrated significant digestive health benefits in a recent Citruslabs study, with 95% of participants reporting constipation relief. The ozonated magnesium formula addresses root causes of digestive issues, supporting …